Dear Dr. Roach: I had a pituitary tumor that was discovered over 25 years ago. For years, I had an MRI with and without dye every six months. Then it changed to once a year. Can you get damage from ...

Journal Editorial Report: The Fed Chief signals rate cuts are coming. As we saw during the Covid pandemic, lab-created experiments can wreak havoc when they escape their confines. Once released, they ...

The advantages of running multiple businesses include risk diversification, multiple sources of income, a broader network, strategic synergies and an increased learning curve. The disadvantages ...

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death. By Gina Kolata A ...

At age 89, Cal Crow plays water volleyball three days a week, then chases that with a 1,000-foot swim; on his off days, he logs at least a mile around his neighborhood — and that’s with a cancer ...

As a person with a chronic illness, I'm no stranger to bloodwork. I used to pore over my lab results, googling the various meanings, and trying not to panic when a test fell out of range. Function ...

The news that Patti Scialfa, Bruce Springsteen’s wife and bandmate, has multiple myeloma is bringing attention to the rare blood cancer. In the new documentary “Road Diary: Bruce Springsteen and the E ...

Corporate growth is the ultimate team sport, relying on multiple functions’ data, technology, and expertise. This is especially true as technology innovation and AI introduce new revenue streams and ...

In todays busy world, many of us have to wear many hats. Having to be a business woman,put out fires,hunt for leads,play like a kid, and many of things. In a new paper published in the Academy of ...

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...

Belantamab mafodotin had single-agent activity in patients with relapsed or refractory multiple myeloma, a finding that supports further evaluation of the agent in combination with standard-care ...